Objective: This study aimed to evaluate the usefulness of some clinical, hematological, and serological parameters in monitoring of RA activity. Methods: This study included 107 RA patients [98 females and 9 males; mean age 46.85 years (range 18–70)]. The patients were classified into four groups based on their disease activity scores. Disease activity scores (DAS-28 ESR and DAS-28 CRP), complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), and anti-citrullinated peptide antibody (ACPA) were measured. Results: Both “DAS-28 ESR and DAS-28 CRP” showed a significant difference among the four disease activity groups regarding family history, disease duration, regularity of treatment intake, response to treatment, and ESR level (P> 0.05). Furthermore, DAS-28 CRP revealed a significant difference (P = 0.021) in the CRP levels across the four disease activity groups. Conclusion: The study found an association between some clinical, hematological, and serological factors and the level of disease activity in patients with RA.
No takes yet. Share an insight, caveat, or question.
Khamees et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: